Mark A. Meltz

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Mark Meltz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Meltz:

Form 4 holding COO GENERAL COUNSEL SECRETARY

Kinnate Biopharma Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
03 Apr 2024
Price
$2.59
Ownership
Direct
Form 4 holding COO GENERAL COUNSEL SECRETARY

Kinnate Biopharma Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
03 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Mark A. Meltz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .